IP Library Granted Patent US 7,939,317
Granted Patent B1
US 7,939,317 · App. 07/839,194 · Granted May 10, 2011

Transgenic animals secreting desired proteins into milk

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,939,317
App. No.
07/839,194
Granted
May 10, 2011
Kind
B1
Abstract

A DNA sequence containing a gene encoding a protein, the gene being under the transcriptional control in the DNA sequence of a mammalian milk protein promoter which does not naturally control the transcription of the gene, such DNA sequence including DNA enabling secretion of the protein.

Claims (13)

1. A DNA construct comprising a gene encoding a protein, said gene being under transcriptional control of a mammalian milk protein promoter sequence which does not naturally control transcription of said gene, said DNA construct further comprising DNA encoding a peptide enabling secretion of said protein.

2. The DNA construct of claim 1 , wherein said secretion enabling peptide comprises a secretion signal peptide which is cleaved from said secretion protein.

3. The DNA construct of claim 1 , wherein said DNA encoding a peptide enabling secretion of said protein is the signal encoding sequence naturally associated with said gene encoding said protein.

4. The DNA construct of claim 1 , wherein said DNA encoding a peptide enabling secretion of said protein is the signal encoding sequence naturally associated with said mammalian milk protein promoter.

5. The DNA construct of claim 1 , wherein said DNA sequence includes a transcriptional stop sequence.

6. The DNA construct of claim 5 , wherein said stop sequence comprises the SV40 virus polyadenylation site.

7. The DNA construct of claim 1 , wherein said gene encodes human tissue plasminogen activator or hepatitis B surface antigen.

8. The DNA construct of claim 1 , wherein said milk protein is a milk serum protein.

9. The DNA construct of claim 8 , wherein said milk serum protein is alpha-lactalbumin.

10. The DNA construct of claim 1 , wherein the mammalian milk protein promoter sequence is the sequence of a milk serum protein promoter.

11. The DNA construct of claim 10 , wherein the milk serum protein promoter is an α-lactalbumin promoter.

12. The DNA construct of claim 10 , wherein the milk serum protein promoter is a β-lactoglobulin promoter.

13. The DNA construct of claim 1 , wherein the mammalian milk protein promoter sequence is the sequence of a casein protein promoter.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2014
From: LFB BIOTECHNOLOGIES S.A.S.U.
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032448/0045 →
RELEASE OF SECURITY INTEREST Recorded Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2010
From: INTEGRATED GENETICS, INC.
To: GENZYME CORPORATION
Reel/Frame 024837/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2010
From: GORDON, KATHERINE; GROET, SUZANNE
To: INTEGRATED GENETICS, INC.
Reel/Frame 024836/0805 →
RELEASE OF SECURITY INTEREST Recorded Mar 2, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING INTELLECTUAL PROPERTY B.V.
Reel/Frame 024016/0508 →
SECURITY INTEREST IN PATENT LICENSES TO GTC BIOTHERAPEUTICS, INC. Recorded Jan 16, 2009
From: GTC BIOTHERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 022119/0936 →
SECURITY INTEREST IN PATENT LICENSES TO GTC BIOTHERAPEUTICS, INC. Recorded Dec 22, 2008
From: GTC BIOTHERAPEUTICS, INC.
To: LFB BIOTECHNOLOGIES S.A.S.U
Reel/Frame 022019/0273 →
GRANT OF A SECURITY INTEREST IN GRANTOR'S (DEBTOR'S) OWNERSHIP RIGHTS TO GRANTEE (SECURED PARTY) Recorded Feb 27, 2006
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017215/0991 →